Thu, August 18, 2022
Wed, August 17, 2022
Tue, August 16, 2022
Mon, August 15, 2022
Fri, August 12, 2022
Thu, August 11, 2022

Mike Kratky Maintained (VRDN) at Buy with Increased Target to $40 on, Aug 15th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-40-on-aug-15th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Mike Kratky of SVB Leerink, Maintained "Viridian Therapeutics, Inc." (VRDN) at Buy with Increased Target from $32 to $40 on, Aug 15th, 2022.

Mike has made no other calls on VRDN in the last 4 months.



There is 1 other peer that has a rating on VRDN. Out of the 1 peers that are also analyzing VRDN, 0 agree with Mike's Rating of Hold.



This is the rating of the analyst that currently disagrees with Mike


  • Kalpit Patel of "B. Riley Securities" Initiated at Strong Buy and Held Target at $25 on, Thursday, June 23rd, 2022